Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Affimed Announces €25 Million Debt Financing Agreement with Silicon Valley Bank
Affimed N.V.January 11, 2021 GMT
€10 million available at closing and up to €15 million available upon achievement of certain milestones
Heidelberg, Germany, January 11, 2021 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that it has entered into a debt financing agreement with Silicon Valley Bank German Branch (SVB) which provides Affimed with up to €25 million in term loans.
“We are pleased to continue our relationship with Silicon Valley Bank,” commented Angus Smith, Chief Financial Officer of Affimed. “This financing will help support the broad development strategy for our ICE® molecules as monotherapies and in combination with natural killer cells and checkpoint inhibitors.�